What is Nubequa (elacestrant), a selective estrogen receptor degrader (SERD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the recommended full dose of elecestrant (Oral Selective Estrogen Receptor Degrader) for patients with advanced or metastatic estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer?
What is the next line of treatment for a 58-year-old patient with metastatic estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer, who has progressed on all available endocrine agents, with rapid liver progression, elevated total bilirubin (T bill), significantly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and an Eastern Cooperative Oncology Group (ECOG) performance status of 1?
What is the recommended use and dosage of Elacestrant (Oral Selective Estrogen Receptor Degrader) for patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer?
What is the indication and usage of Nubequa (elacestrant) for breast cancer treatment?
What is the role of Selective Estrogen Receptor Downregulators (SERDs) and Selective Estrogen Receptor Modulators (SERMs) in the treatment of early-stage Estrogen Receptor (ER)-positive breast cancer?
What are the grades of cystocele?
What are the treatment options for patients with symptoms of Benign Prostatic Hyperplasia (BPH) as assessed by the International Prostate Symptom Score (IPSS)?
Can cancer increase the white blood cell (WBC) count?
What is darolutamide?
What precautions can be taken to prevent the spread of molluscum contagiosum?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.